APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human Chorionic Gonadotropin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant Human Chorionic Gonadotropin Industry Growth and Trends Forecast to 2032

20 December 202594 pages

Choose your research edition.

Industry ResearchRecombinant Human Chorionic Gonadotropin Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human Chorionic Gonadotropin Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Recombinant Human Chorionic Gonadotropin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human Chorionic Gonadotropin Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human Chorionic Gonadotropin Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Recombinant Human Chorionic Gonadotropin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant Human Chorionic Gonadotropin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant Human Chorionic Gonadotropin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Human Chorionic Gonadotropin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Human Chorionic Gonadotropin include Merck, Ferring Pharmaceuticals, Wellona Pharma, Serum International Ltd, Schering Plough, Marvel Oceanic Private Limited, Facmed Pharmaceuticals and Bionomics Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant Human Chorionic Gonadotropin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant Human Chorionic Gonadotropin market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Human Chorionic Gonadotropin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Human Chorionic Gonadotropin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Human Chorionic Gonadotropin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant Human Chorionic Gonadotropin Market by Company

Merck

Ferring Pharmaceuticals

Wellona Pharma

Serum International Ltd

Schering Plough

Marvel Oceanic Private Limited

Facmed Pharmaceuticals

Bionomics Lifesciences

Recombinant Human Chorionic Gonadotropin Segment by Type

Intramuscular Powder for Injection

Subcutaneous Solution for Injection

Recombinant Human Chorionic Gonadotropin Segment by Application

Female

Male

Recombinant Human Chorionic Gonadotropin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human Chorionic Gonadotropin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human Chorionic Gonadotropin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human Chorionic Gonadotropin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Human Chorionic Gonadotropin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant Human Chorionic Gonadotropin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Intramuscular Powder for Injection Table 2. Major Company of Subcutaneous Solution for Injection Table 3. Global Recombinant Human Chorionic Gonadotropin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Recombinant Human Chorionic Gonadotropin Sales by Type (2021-2026) & (k units) Table 5. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Recombinant Human Chorionic Gonadotropin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Type (2021-2026) Table 8. Global Recombinant Human Chorionic Gonadotropin Price by Type (2021-2026) & (US$/unit) Table 9. Global Recombinant Human Chorionic Gonadotropin Sales by Type (2027-2032) & (k units) Table 10. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Recombinant Human Chorionic Gonadotropin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Type (2027-2032) Table 13. Global Recombinant Human Chorionic Gonadotropin Price by Type (2027-2032) & (US$/unit) Table 14. North America Recombinant Human Chorionic Gonadotropin Sales by Type (2021-2026) & (k units) Table 15. North America Recombinant Human Chorionic Gonadotropin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Recombinant Human Chorionic Gonadotropin Sales by Type (2021-2026) & (k units) Table 17. Europe Recombinant Human Chorionic Gonadotropin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Recombinant Human Chorionic Gonadotropin Sales by Type (2021-2026) & (k units) Table 21. Latin America Recombinant Human Chorionic Gonadotropin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales by Type (2021-2026) & (US$ Million) Table 24. Recombinant Human Chorionic Gonadotropin Industry Trends Table 25. Recombinant Human Chorionic Gonadotropin Industry Drivers Table 26. Recombinant Human Chorionic Gonadotropin Industry Opportunities and Challenges Table 27. Recombinant Human Chorionic Gonadotropin Industry Restraints Table 28. Global Recombinant Human Chorionic Gonadotropin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Recombinant Human Chorionic Gonadotropin Revenue Market Share by Company (2021-2026) Table 30. Global Recombinant Human Chorionic Gonadotropin Sales by Company (2021-2026) & (k units) Table 31. Global Recombinant Human Chorionic Gonadotropin Sales Share by Company (2021-2026) Table 32. Global Recombinant Human Chorionic Gonadotropin Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Recombinant Human Chorionic Gonadotropin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Recombinant Human Chorionic Gonadotropin Major Company Production Sites and Headquarters Table 35. Global Recombinant Human Chorionic Gonadotropin Company, Product Type & Application Table 36. Global Recombinant Human Chorionic Gonadotropin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Recombinant Human Chorionic Gonadotropin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Recombinant Human Chorionic Gonadotropin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Recombinant Human Chorionic Gonadotropin Sales by Region (2021-2026) & (k units) Table 41. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Recombinant Human Chorionic Gonadotropin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Region (2021-2026) Table 44. Global Recombinant Human Chorionic Gonadotropin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Recombinant Human Chorionic Gonadotropin Sales by Region (2027-2032) & (k units) Table 46. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Recombinant Human Chorionic Gonadotropin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Region (2027-2032) Table 49. Global Recombinant Human Chorionic Gonadotropin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Recombinant Human Chorionic Gonadotropin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Recombinant Human Chorionic Gonadotropin Sales by Application (2021-2026) & (k units) Table 52. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Recombinant Human Chorionic Gonadotropin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Application (2021-2026) Table 55. Global Recombinant Human Chorionic Gonadotropin Price by Application (2021-2026) & (US$/unit) Table 56. Global Recombinant Human Chorionic Gonadotropin Sales by Application (2027-2032) & (k units) Table 57. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Recombinant Human Chorionic Gonadotropin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Application (2027-2032) Table 60. Global Recombinant Human Chorionic Gonadotropin Price by Application (2027-2032) & (US$/unit) Table 61. North America Recombinant Human Chorionic Gonadotropin Sales by Application (2021-2026) & (k units) Table 62. North America Recombinant Human Chorionic Gonadotropin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Recombinant Human Chorionic Gonadotropin Sales by Application (2021-2026) & (k units) Table 64. Europe Recombinant Human Chorionic Gonadotropin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Recombinant Human Chorionic Gonadotropin Sales by Application (2021-2026) & (k units) Table 68. Latin America Recombinant Human Chorionic Gonadotropin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Recombinant Human Chorionic Gonadotropin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Merck Recombinant Human Chorionic Gonadotropin Product Portfolio Table 75. Merck Recent Development Table 76. Ferring Pharmaceuticals Company Information Table 77. Ferring Pharmaceuticals Business Overview Table 78. Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product Portfolio Table 80. Ferring Pharmaceuticals Recent Development Table 81. Wellona Pharma Company Information Table 82. Wellona Pharma Business Overview Table 83. Wellona Pharma Recombinant Human Chorionic Gonadotropin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Wellona Pharma Recombinant Human Chorionic Gonadotropin Product Portfolio Table 85. Wellona Pharma Recent Development Table 86. Serum International Ltd Company Information Table 87. Serum International Ltd Business Overview Table 88. Serum International Ltd Recombinant Human Chorionic Gonadotropin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Serum International Ltd Recombinant Human Chorionic Gonadotropin Product Portfolio Table 90. Serum International Ltd Recent Development Table 91. Schering Plough Company Information Table 92. Schering Plough Business Overview Table 93. Schering Plough Recombinant Human Chorionic Gonadotropin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Schering Plough Recombinant Human Chorionic Gonadotropin Product Portfolio Table 95. Schering Plough Recent Development Table 96. Marvel Oceanic Private Limited Company Information Table 97. Marvel Oceanic Private Limited Business Overview Table 98. Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Product Portfolio Table 100. Marvel Oceanic Private Limited Recent Development Table 101. Facmed Pharmaceuticals Company Information Table 102. Facmed Pharmaceuticals Business Overview Table 103. Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product Portfolio Table 105. Facmed Pharmaceuticals Recent Development Table 106. Bionomics Lifesciences Company Information Table 107. Bionomics Lifesciences Business Overview Table 108. Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Product Portfolio Table 110. Bionomics Lifesciences Recent Development Table 111. North America Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. North America Recombinant Human Chorionic Gonadotropin Sales by Country (2021-2026) & (k units) Table 113. North America Recombinant Human Chorionic Gonadotropin Sales Market Share by Country (2021-2026) Table 114. North America Recombinant Human Chorionic Gonadotropin Sales Forecast by Country (2027-2032) & (k units) Table 115. North America Recombinant Human Chorionic Gonadotropin Sales Market Share Forecast by Country (2027-2032) Table 116. North America Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Recombinant Human Chorionic Gonadotropin Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Recombinant Human Chorionic Gonadotropin Market Share by Country (2021-2026) Table 119. North America Recombinant Human Chorionic Gonadotropin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Recombinant Human Chorionic Gonadotropin Market Share Forecast by Country (2027-2032) Table 121. Europe Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Europe Recombinant Human Chorionic Gonadotropin Sales by Country (2021-2026) & (k units) Table 123. Europe Recombinant Human Chorionic Gonadotropin Sales Market Share by Country (2021-2026) Table 124. Europe Recombinant Human Chorionic Gonadotropin Sales Forecast by Country (2027-2032) & (k units) Table 125. Europe Recombinant Human Chorionic Gonadotropin Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Recombinant Human Chorionic Gonadotropin Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Recombinant Human Chorionic Gonadotropin Market Share by Country (2021-2026) Table 129. Europe Recombinant Human Chorionic Gonadotropin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Recombinant Human Chorionic Gonadotropin Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales by Country (2021-2026) & (k units) Table 133. Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales Forecast by Country (2027-2032) & (k units) Table 135. Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Recombinant Human Chorionic Gonadotropin Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Recombinant Human Chorionic Gonadotropin Market Share by Country (2021-2026) Table 139. Asia-Pacific Recombinant Human Chorionic Gonadotropin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Recombinant Human Chorionic Gonadotropin Market Share Forecast by Country (2027-2032) Table 141. Latin America Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Latin America Recombinant Human Chorionic Gonadotropin Sales by Country (2021-2026) & (k units) Table 143. Latin America Recombinant Human Chorionic Gonadotropin Sales Market Share by Country (2021-2026) Table 144. Latin America Recombinant Human Chorionic Gonadotropin Sales Forecast by Country (2027-2032) & (k units) Table 145. Latin America Recombinant Human Chorionic Gonadotropin Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Recombinant Human Chorionic Gonadotropin Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Recombinant Human Chorionic Gonadotropin Market Share by Country (2021-2026) Table 149. Latin America Recombinant Human Chorionic Gonadotropin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Recombinant Human Chorionic Gonadotropin Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales by Country (2021-2026) & (k units) Table 153. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales Forecast by Country (2027-2032) & (k units) Table 155. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Recombinant Human Chorionic Gonadotropin Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Recombinant Human Chorionic Gonadotropin Market Share by Country (2021-2026) Table 159. Middle East and Africa Recombinant Human Chorionic Gonadotropin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Recombinant Human Chorionic Gonadotropin Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Recombinant Human Chorionic Gonadotropin Distributors List Table 164. Recombinant Human Chorionic Gonadotropin Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Recombinant Human Chorionic Gonadotropin Image Figure 2. Global Recombinant Human Chorionic Gonadotropin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human Chorionic Gonadotropin Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Human Chorionic Gonadotropin Sales (2021-2032) & (k units) Figure 5. Intramuscular Powder for Injection Image Figure 6. Global Intramuscular Powder for Injection Sales YoY Growth (2021-2032) & (k units) Figure 7. Subcutaneous Solution for Injection Image Figure 8. Global Subcutaneous Solution for Injection Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Recombinant Human Chorionic Gonadotropin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Recombinant Human Chorionic Gonadotropin Market Share by Type 2025 VS 2032 Figure 11. North America Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Type in 2025 Figure 12. North America Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Type in 2025 Figure 13. Europe Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Recombinant Human Chorionic Gonadotropin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Female Image Figure 24. Global Female Sales YoY Growth (2021-2032) & (k units) Figure 25. Male Image Figure 26. Global Male Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Recombinant Human Chorionic Gonadotropin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Recombinant Human Chorionic Gonadotropin Market Share by Application 2025 VS 2032 Figure 29. North America Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Application in 2025 Figure 30. North America Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Application in 2025 Figure 31. Europe Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Application in 2025 Figure 32. Europe Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Application in 2025 Figure 35. Latin America Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Application in 2025 Figure 39. North America Recombinant Human Chorionic Gonadotropin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Recombinant Human Chorionic Gonadotropin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Recombinant Human Chorionic Gonadotropin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Recombinant Human Chorionic Gonadotropin Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Recombinant Human Chorionic Gonadotropin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Recombinant Human Chorionic Gonadotropin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Recombinant Human Chorionic Gonadotropin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Recombinant Human Chorionic Gonadotropin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Recombinant Human Chorionic Gonadotropin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Recombinant Human Chorionic Gonadotropin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Recombinant Human Chorionic Gonadotropin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Recombinant Human Chorionic Gonadotropin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Recombinant Human Chorionic Gonadotropin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Recombinant Human Chorionic Gonadotropin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Recombinant Human Chorionic Gonadotropin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Recombinant Human Chorionic Gonadotropin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Recombinant Human Chorionic Gonadotropin Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Recombinant Human Chorionic Gonadotropin Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Intramuscular Powder for Injection
  • Subcutaneous Solution for Injection
Applications
  • Female
  • Male
Companies covered
  • Merck
  • Ferring Pharmaceuticals
  • Wellona Pharma
  • Serum International Ltd
  • Schering Plough
  • Marvel Oceanic Private Limited
  • Facmed Pharmaceuticals
  • Bionomics Lifesciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Human Chorionic Gonadotropin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant Human Chorionic Gonadotropin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant Human Chorionic Gonadotropin Market by Type
  6. 1.3.1 Intramuscular Powder for Injection
  7. 1.3.2 Subcutaneous Solution for Injection
  8. 1.4 Global Recombinant Human Chorionic Gonadotropin Market Size by Type
  9. 1.4.1 Global Recombinant Human Chorionic Gonadotropin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Recombinant Human Chorionic Gonadotropin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Recombinant Human Chorionic Gonadotropin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Recombinant Human Chorionic Gonadotropin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Recombinant Human Chorionic Gonadotropin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Recombinant Human Chorionic Gonadotropin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant Human Chorionic Gonadotropin Industry Trends
  2. 2.2 Recombinant Human Chorionic Gonadotropin Industry Drivers
  3. 2.3 Recombinant Human Chorionic Gonadotropin Industry Opportunities and Challenges
  4. 2.4 Recombinant Human Chorionic Gonadotropin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant Human Chorionic Gonadotropin Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant Human Chorionic Gonadotropin Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant Human Chorionic Gonadotropin Price (2021-2026)
  4. 3.4 Global Recombinant Human Chorionic Gonadotropin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Human Chorionic Gonadotropin Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant Human Chorionic Gonadotropin Company, Product Type & Application
  7. 3.7 Global Recombinant Human Chorionic Gonadotropin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Human Chorionic Gonadotropin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Human Chorionic Gonadotropin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Human Chorionic Gonadotropin Tier 1, Tier 2, and Tier 3
4 Recombinant Human Chorionic Gonadotropin Regional Status and Outlook
  1. 4.1 Global Recombinant Human Chorionic Gonadotropin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant Human Chorionic Gonadotropin Historic Market Size by Region
  3. 4.2.1 Global Recombinant Human Chorionic Gonadotropin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant Human Chorionic Gonadotropin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant Human Chorionic Gonadotropin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant Human Chorionic Gonadotropin Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant Human Chorionic Gonadotropin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant Human Chorionic Gonadotropin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant Human Chorionic Gonadotropin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Human Chorionic Gonadotropin by Application
  1. 5.1 Recombinant Human Chorionic Gonadotropin Market by Application
  2. 5.1.1 Female
  3. 5.1.2 Male
  4. 5.2 Global Recombinant Human Chorionic Gonadotropin Market Size by Application
  5. 5.2.1 Global Recombinant Human Chorionic Gonadotropin Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Recombinant Human Chorionic Gonadotropin Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Recombinant Human Chorionic Gonadotropin Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Recombinant Human Chorionic Gonadotropin Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Recombinant Human Chorionic Gonadotropin Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Recombinant Human Chorionic Gonadotropin Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Recombinant Human Chorionic Gonadotropin Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Ferring Pharmaceuticals
  8. 6.2.1 Ferring Pharmaceuticals Company Information
  9. 6.2.2 Ferring Pharmaceuticals Business Overview
  10. 6.2.3 Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product Portfolio
  12. 6.2.5 Ferring Pharmaceuticals Recent Developments
  13. 6.3 Wellona Pharma
  14. 6.3.1 Wellona Pharma Company Information
  15. 6.3.2 Wellona Pharma Business Overview
  16. 6.3.3 Wellona Pharma Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Wellona Pharma Recombinant Human Chorionic Gonadotropin Product Portfolio
  18. 6.3.5 Wellona Pharma Recent Developments
  19. 6.4 Serum International Ltd
  20. 6.4.1 Serum International Ltd Company Information
  21. 6.4.2 Serum International Ltd Business Overview
  22. 6.4.3 Serum International Ltd Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Serum International Ltd Recombinant Human Chorionic Gonadotropin Product Portfolio
  24. 6.4.5 Serum International Ltd Recent Developments
  25. 6.5 Schering Plough
  26. 6.5.1 Schering Plough Company Information
  27. 6.5.2 Schering Plough Business Overview
  28. 6.5.3 Schering Plough Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Schering Plough Recombinant Human Chorionic Gonadotropin Product Portfolio
  30. 6.5.5 Schering Plough Recent Developments
  31. 6.6 Marvel Oceanic Private Limited
  32. 6.6.1 Marvel Oceanic Private Limited Company Information
  33. 6.6.2 Marvel Oceanic Private Limited Business Overview
  34. 6.6.3 Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Product Portfolio
  36. 6.6.5 Marvel Oceanic Private Limited Recent Developments
  37. 6.7 Facmed Pharmaceuticals
  38. 6.7.1 Facmed Pharmaceuticals Company Information
  39. 6.7.2 Facmed Pharmaceuticals Business Overview
  40. 6.7.3 Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product Portfolio
  42. 6.7.5 Facmed Pharmaceuticals Recent Developments
  43. 6.8 Bionomics Lifesciences
  44. 6.8.1 Bionomics Lifesciences Company Information
  45. 6.8.2 Bionomics Lifesciences Business Overview
  46. 6.8.3 Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Product Portfolio
  48. 6.8.5 Bionomics Lifesciences Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant Human Chorionic Gonadotropin Sales by Country
  2. 7.1.1 North America Recombinant Human Chorionic Gonadotropin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant Human Chorionic Gonadotropin Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant Human Chorionic Gonadotropin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant Human Chorionic Gonadotropin Market Size by Country
  6. 7.2.1 North America Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant Human Chorionic Gonadotropin Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant Human Chorionic Gonadotropin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant Human Chorionic Gonadotropin Sales by Country
  2. 8.1.1 Europe Recombinant Human Chorionic Gonadotropin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant Human Chorionic Gonadotropin Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant Human Chorionic Gonadotropin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant Human Chorionic Gonadotropin Market Size by Country
  6. 8.2.1 Europe Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant Human Chorionic Gonadotropin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant Human Chorionic Gonadotropin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant Human Chorionic Gonadotropin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant Human Chorionic Gonadotropin Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant Human Chorionic Gonadotropin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant Human Chorionic Gonadotropin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant Human Chorionic Gonadotropin Sales by Country
  2. 10.1.1 South America Recombinant Human Chorionic Gonadotropin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant Human Chorionic Gonadotropin Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant Human Chorionic Gonadotropin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant Human Chorionic Gonadotropin Market Size by Country
  6. 10.2.1 South America Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant Human Chorionic Gonadotropin Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant Human Chorionic Gonadotropin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant Human Chorionic Gonadotropin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant Human Chorionic Gonadotropin Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant Human Chorionic Gonadotropin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant Human Chorionic Gonadotropin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant Human Chorionic Gonadotropin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant Human Chorionic Gonadotropin Value Chain Analysis
  2. 12.1.1 Recombinant Human Chorionic Gonadotropin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant Human Chorionic Gonadotropin Production Mode & Process
  7. 12.2 Recombinant Human Chorionic Gonadotropin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant Human Chorionic Gonadotropin Distributors
  10. 12.2.3 Recombinant Human Chorionic Gonadotropin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst